These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33115436)

  • 41. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning).
    Jefferies HJ; Virk B; Schiller B; Moran J; McIntyre CW
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1326-32. PubMed ID: 21597028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.
    Wu CK; Yang YH; Juang JJ; Wang YC; Tsai CT; Lai LP; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
    Medicine (Baltimore); 2015 Jan; 94(3):e424. PubMed ID: 25621694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.
    Kaseda R; Tsuchida Y; Gamboa JL; Zhong J; Zhang L; Yang H; Dikalova A; Bian A; Davies S; Fogo AF; Linton MF; Brown NJ; Ikizler TA; Kon V
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):582-591. PubMed ID: 29691148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive value of cardiac troponin T and I in hemodialysis patients.
    Kalaji FR; Albitar S
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):939-45. PubMed ID: 22982904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
    Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
    Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of microvascular dysfunction with cardiovascular outcomes: The cardiac, endothelial function and arterial stiffness in ESRD (CERES) cohort.
    Ayer A; Mills C; Donovan C; Christenson RH; Ganz P; Dubin RF
    Hemodial Int; 2019 Jan; 23(1):58-68. PubMed ID: 30724445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.
    Roberts MA; Darssan D; Badve SV; Carroll RP; Fahim MA; Haluska BA; Hawley CM; Isbel NM; Marshall MR; Pascoe EM; Pedagogos E; Pilmore HL; Snelling P; Stanton T; Tan KS; Tonkin AM; Vergara LA; Ierino FL
    Kidney Blood Press Res; 2017; 42(6):1033-1044. PubMed ID: 29197871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.
    Haynes R; Judge PK; Staplin N; Herrington WG; Storey BC; Bethel A; Bowman L; Brunskill N; Cockwell P; Hill M; Kalra PA; McMurray JJV; Taal M; Wheeler DC; Landray MJ; Baigent C
    Circulation; 2018 Oct; 138(15):1505-1514. PubMed ID: 30002098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure).
    O'Meara E; Prescott MF; Claggett B; Rouleau JL; Chiang LM; Solomon SD; Packer M; McMurray JJV; Zile MR
    Circ Heart Fail; 2018 May; 11(5):e004446. PubMed ID: 29748349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal patterns of N-terminal pro B-type natriuretic peptide, troponin T, and C-reactive protein in relation to the dynamics of echocardiographic parameters in heart failure patients.
    Klimczak-Tomaniak D; van den Berg VJ; Strachinaru M; Akkerhuis KM; Baart S; Caliskan K; Manintveld OC; Umans V; Geleijnse M; Boersma E; van Dalen BM; Kardys I
    Eur Heart J Cardiovasc Imaging; 2020 Sep; 21(9):1005-1012. PubMed ID: 31596459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
    Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E; Camerini C; Gaggia P; Zubani R; Cancarini G
    Am J Nephrol; 2018; 48(2):79-86. PubMed ID: 30071530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
    Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
    Am J Cardiol; 2016 Feb; 117(3):376-81. PubMed ID: 26739393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study.
    Myhre PL; Tiainen M; Pettilä V; Vaahersalo J; Hagve TA; Kurola J; Varpula T; Omland T; Røsjø H;
    Resuscitation; 2016 Jul; 104():12-8. PubMed ID: 27109503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients.
    Toussaint ND; Polkinghorne KR; Kerr PG
    Hemodial Int; 2008 Apr; 12(2):254-63. PubMed ID: 18394060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.